List view / Grid view
23 February 2016 | By Victoria White
ONCEMRK is evaluating an investigational once-daily formulation of Isentress (raltegravir), known as raltegravir 600 mg, for previously untreated HIV-1 infected adults...
23 February 2016 | By L.B. Bohle Maschinen + Verfahren GmbH
The investments in the future have paid off for L.B. Bohle Maschinen + Verfahren GmbH in the 2015 business year...
23 February 2016 | By Victoria White
Ibrance is approved for the treatment of HR+, HER2- advanced or metastatic breast cancer in combination with fulvestrant in women with disease progression following endocrine therapy...
23 February 2016 | By Victoria White
The Phase III FRAME study evaluated UCB and Amgen's romosozumab in postmenopausal women with osteoporosis...
23 February 2016 | By Victoria White
This NDA submission is based on data from two Phase 3 studies of insulin glargine and lixisenatide in patients with with type 2 diabetes...
22 February 2016 | By Copley Scientific
The latest version of ‘Quality Solutions for the Testing of Pharmaceuticals’ from Copley Scientific provides detailed information for those seeking assistance with the interpretation and application of regulatory guidance, as well as highlighting new additions to the company’s extensive range...
Blood transfusions have been used successfully since the early 1900s, and blood banks have been in use since 1914. After donation, whole blood is separated into several components for processing and storage under different conditions, and one of these components is the red blood cell fraction.
A placebo is a simulated or otherwise medically ineffectual treatment for a disease or other medical condition intended to make the recipient believe they are receiving something they are not in order to establish whether the true active agent has a noticeable remedy to the ailment it is intended to…
19 February 2016 | By Victoria White
After the first year, patients with a history of heart attack can now continue to be treated with Brilique at the lower dose of 60mg twice daily...
19 February 2016 | By Victoria White
According to a new study, less than 40% of the results of clinical trials conducted at leading academic medical centres were shared within two years of completion...
19 February 2016 | By Victoria White
In combination with the current standard of care, Zurampic provides a dual mechanism of action to increase excretion and decrease production of uric acid...
19 February 2016 | By Victoria White
PKC412 (midostaurin) is an investigational treatment for adults with newly-diagnosed acute myeloid leukaemia who are FLT3 mutation-positive...
19 February 2016 | By Victoria White
Acelity has announced a partnership with Mediq to exclusively distribute Acelity’s advanced wound care and regenerative medicine portfolio in Denmark, Finland, Norway and Sweden.
18 February 2016 | By Victoria White
Reductions in brain lesions at week 24 were maintained while relapses were further reduced at week 72 with continuous ozanimod treatment...
Yusen Logistics UK (YLUK) has launched a direct ‘Less than Container Load’ (LCL) own consolidation service from Southampton, UK to Shanghai, China.
